Medify Solutions Ltd (Pink Sheets: MFYS) Extraordinary Dividend Eligibility Closes on Friday 28th July, 2006
Toronto (ots/PRNewswire)
The board of Medify Solutions Limited has announced the confirmation of the extraordinary share dividend following its European subsidiary float. As stated, all shareholders in Medify Solutions Limited (Pink Sheets: MFYS) will receive a share for share dividend granted on floatation. For every share held in Medify Solutions Limited, existing share holders will receive a reciprocal free trading share in the European operation. Eligibility for this dividend is valid for all shareholders and closes at the close of the market on Friday 28th July 2006. Jonathan Bryant, Executive Chairman, said: "The announcement of the closing date for eligibility for the shareholders' extraordinary dividend is a clear mark of intent and a demonstration of the progress of the company. I hope all Medify shareholders will take confidence in this announcement and look forward to the future and the success of Medify, now on a global basis." He added: "I congratulate the team for making this a reality and we as shareholders should be extremely excited about this confirmation. The plans, the vision and the success are now becoming the reality for the Medify Group of companies. I believe these will prove to be exciting and profitable times for anyone associated with Medify especially those who have a shareholding." Every share held by a shareholder at the closing of the market on Friday July 28th 2006 will be entitled to the extraordinary dividend.
Medify Solutions Inc. (Pink Sheets: MFYS) is the first business to have developed a Secure Remote Access product, addressing critical requirements of the UK National Health Service, and many other medical computer systems, bringing the latest flexible integrated wireless and web-based technologies for healthcare revision. MedifyRemote, its leading product, is an application that allows remote access to a patient's record through a Pocket PC. This solution is not specific to any single clinical data system, but applicable to all the NHS /Healthcare software systems in any healthcare market. The company's website is http://www.medifysolutions.com.
This news release contains forward-looking statements that are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of such forward-looking statements. The words "estimate," "project," "intends," "expects," "believes," and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future performance of Medify Solutions Limited, see "Risk Factors" in the Company's Annual Report on Form 10-KSB and its other filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made and the Company undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.
Contact:
Medify Press Office: press@medifysolutions.com. Jonathan Bryant,
Group Chairman, +44-(0)845-034-4090